Kaléo is a global leader in drug-delivery technology and auto-injector innovation, providing millions of patients and emergency responders with security and peace of mind.
Founded 25 years ago, Kaléo was inspired by the personal passion of its founders to overcome the limitations of anaphylaxis rescue medications. This mission has led to a growing portfolio of drug-device combinations designed to deliver lifesaving and enhancing treatments with precision and reliability.
The company is driven by a commitment to being purposefully precise, improving quality of life, and strengthening global health security through innovative solutions that deliver protection and peace of mind.
